NCT00430651 - Docetaxel and Carboplatin Versus Docetaxel as Second Line Treatment in Patients With Non-Small-Cell Lung Carcinoma (NSCLC) | Biotech Hunter

Enrollment

135

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG

Docetaxel

Docetaxel 50 mg/m2 IV on days 1 and 15 every 28 days for 6 cycles

DRUG

Carboplatin

Docetaxel 50 mg/m2 IV over 1 hour followed by Carboplatin 4 AUC IV over 1 hour on days 1 and 15

Trial Locations (10)

University Hospital of Crete, Heraklion

University General Hospital of Alexandroupolis, Dep of Medical Oncology, Alexandroupoli

"IASO General Hospital of Athnes, Dep of Medical Oncology", Athens

"Laikon General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine", Athens

"Sotiria General Hospital, 1st, 3rd, 6th, 7th, 8th Dep of Pulmonary Diseases", Athens

401 Military Hospital, Medical Oncology Unit, Athens

Air Forces Military Hospital, Dep of Medical Oncology, Athens

Sismanogleio General Hospital, 1st, 2nd Dep of Pulmonary Diseases, Athens

"Metaxa's Anticancer Hospital of Pireaus", Piraeus

"Theagenion Anticancer Hospital of Thessaloniki", Thessaloniki